- Report
- March 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- February 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- January 2026
- 186 Pages
Global
From €3950EUR$4,500USD£3,437GBP
- Report
- November 2025
- 250 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- September 2025
- 250 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- April 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- February 2026
- 392 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 384 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 485 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 140 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 402 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 407 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 378 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 375 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 492 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 286 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 392 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 204 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 384 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 361 Pages
Global
From €5135EUR$5,850USD£4,467GBP

Age-related Macular Degeneration (AMD) is a degenerative eye condition that affects the macula, the part of the eye responsible for central vision. It is the leading cause of vision loss in people over the age of 50. AMD is a major concern for the optical industry, as it can lead to severe vision impairment and blindness.
Optical companies are developing treatments and technologies to help diagnose and manage AMD. These include optical coherence tomography (OCT) imaging, which can detect early signs of AMD, and anti-VEGF drugs, which can slow the progression of the disease. Additionally, companies are developing new lenses and other optical devices to help improve vision in those with AMD.
Companies in the AMD market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more